Episode Details

Scientists are harnessing CAR-T cell therapy, traditionally used for cancer treatment, to combat HIV. Early results from a small study show two individuals with undetectable HIV levels after nearly two and a year of stopping antiretroviral drugs. This approach aims to provide a long-term control of HIV without lifelong medication, addressing accessibility and affordability challenges. The trial is still in its early stages, focusing on safety and feasibility, with promising results in some participants. The road ahead involves making this advanced therapy more affordable and accessible, potentially even engineering these cells directly within the body.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/9cd73d0f8ac5eddf